25 XP   0   0   10

SK Bioscience Co Ltd
Buy, Hold or Sell?

Let's analyse SK Bioscience Co Ltd together

PenkeI guess you are interested in SK Bioscience Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SK Bioscience Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SK Bioscience Co Ltd

I send you an email if I find something interesting about SK Bioscience Co Ltd.

Quick analysis of SK Bioscience Co Ltd (30 sec.)










What can you expect buying and holding a share of SK Bioscience Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩22,177.59
Expected worth in 1 year
₩21,684.97
How sure are you?
78.6%

+ What do you gain per year?

Total Gains per Share
₩-492.62
Return On Investment
-0.8%

For what price can you sell your share?

Current Price per Share
₩58,200.00
Expected price per share
₩0 - ₩63,100
How sure are you?
50%

1. Valuation of SK Bioscience Co Ltd (5 min.)




Live pricePrice per Share (EOD)

₩58,200.00

Intrinsic Value Per Share

₩-8,551.47 - ₩-10,832.95

Total Value Per Share

₩13,626.12 - ₩11,344.64

2. Growth of SK Bioscience Co Ltd (5 min.)




Is SK Bioscience Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.1b$16.4m1.4%

How much money is SK Bioscience Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.9m$21.4m-$17.5m-448.7%
Net Profit Margin-26.0%27.0%--

How much money comes from the company's main activities?

3. Financial Health of SK Bioscience Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#49 / 1016

Most Revenue
#129 / 1016

Most Profit
#119 / 1016

Most Efficient
#511 / 1016

What can you expect buying and holding a share of SK Bioscience Co Ltd? (5 min.)

Welcome investor! SK Bioscience Co Ltd's management wants to use your money to grow the business. In return you get a share of SK Bioscience Co Ltd.

What can you expect buying and holding a share of SK Bioscience Co Ltd?

First you should know what it really means to hold a share of SK Bioscience Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of SK Bioscience Co Ltd is ₩58,200. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SK Bioscience Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SK Bioscience Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩22,177.59. Based on the TTM, the Book Value Change Per Share is ₩-123.15 per quarter. Based on the YOY, the Book Value Change Per Share is ₩456.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SK Bioscience Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%0.050.0%0.280.0%0.350.0%0.350.0%
Usd Book Value Change Per Share-0.170.0%-0.090.0%0.320.0%1.110.0%1.110.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.170.0%-0.090.0%0.320.0%1.110.0%1.110.0%
Usd Price Per Share50.40-50.98-71.98-73.86-73.86-
Price to Earnings Ratio331.66-41.47-68.85-46.12-46.12-
Price-to-Total Gains Ratio-290.39--151.95-245.52-81.62-81.62-
Price to Book Ratio3.25-3.26-4.70-5.25-5.25-
Price-to-Total Gains Ratio-290.39--151.95-245.52-81.62-81.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share40.74
Number of shares24
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.091.11
Usd Total Gains Per Share-0.091.11
Gains per Quarter (24 shares)-2.0726.61
Gains per Year (24 shares)-8.28106.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-8-18010696
20-17-260213202
30-25-340319308
40-33-420426414
50-41-500532520
60-50-580639626
70-58-660745732
80-66-740852838
90-74-820958944
100-83-90010651050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%12.02.00.085.7%12.02.00.085.7%12.02.00.085.7%
Book Value Change Per Share1.03.00.025.0%9.03.00.075.0%11.03.00.078.6%11.03.00.078.6%11.03.00.078.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share1.03.00.025.0%9.03.00.075.0%11.03.00.078.6%11.03.00.078.6%11.03.00.078.6%

Fundamentals of SK Bioscience Co Ltd

About SK Bioscience Co Ltd

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.

Fundamental data was last updated by Penke on 2024-04-01 06:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of SK Bioscience Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit SK Bioscience Co Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 4.6% means that ₩0.05 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SK Bioscience Co Ltd:

  • The MRQ is 4.6%. The company is making a profit. +1
  • The TTM is -26.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ4.6%TTM-26.0%+30.6%
TTM-26.0%YOY27.0%-53.0%
TTM-26.0%5Y14.3%-40.3%
5Y14.3%10Y14.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6%-197.2%+201.8%
TTM-26.0%-210.4%+184.4%
YOY27.0%-279.3%+306.3%
5Y14.3%-436.8%+451.1%
10Y14.3%-599.3%+613.6%
1.1.2. Return on Assets

Shows how efficient SK Bioscience Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • 0.2% Return on Assets means that SK Bioscience Co Ltd generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SK Bioscience Co Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.3%-0.1%
TTM0.3%YOY1.5%-1.2%
TTM0.3%5Y2.4%-2.1%
5Y2.4%10Y2.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-13.6%+13.8%
TTM0.3%-12.9%+13.2%
YOY1.5%-11.9%+13.4%
5Y2.4%-14.2%+16.6%
10Y2.4%-16.2%+18.6%
1.1.3. Return on Equity

Shows how efficient SK Bioscience Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • 0.2% Return on Equity means SK Bioscience Co Ltd generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SK Bioscience Co Ltd:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.3%-0.1%
TTM0.3%YOY1.8%-1.5%
TTM0.3%5Y3.5%-3.2%
5Y3.5%10Y3.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-17.0%+17.2%
TTM0.3%-16.1%+16.4%
YOY1.8%-15.4%+17.2%
5Y3.5%-20.0%+23.5%
10Y3.5%-21.1%+24.6%

1.2. Operating Efficiency of SK Bioscience Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient SK Bioscience Co Ltd is operating .

  • Measures how much profit SK Bioscience Co Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SK Bioscience Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY23.7%-23.7%
TTM-5Y21.9%-21.9%
5Y21.9%10Y21.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM--224.4%+224.4%
YOY23.7%-288.4%+312.1%
5Y21.9%-475.2%+497.1%
10Y21.9%-624.7%+646.6%
1.2.2. Operating Ratio

Measures how efficient SK Bioscience Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are ₩1.77 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of SK Bioscience Co Ltd:

  • The MRQ is 1.769. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.378. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.769TTM2.378-0.610
TTM2.378YOY0.722+1.657
TTM2.3785Y1.311+1.068
5Y1.31110Y1.3110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7692.997-1.228
TTM2.3783.247-0.869
YOY0.7223.766-3.044
5Y1.3115.675-4.364
10Y1.3117.857-6.546

1.3. Liquidity of SK Bioscience Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if SK Bioscience Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.20 means the company has ₩10.20 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of SK Bioscience Co Ltd:

  • The MRQ is 10.197. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.642. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.197TTM7.642+2.556
TTM7.642YOY4.940+2.702
TTM7.6425Y5.051+2.591
5Y5.05110Y5.0510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1973.930+6.267
TTM7.6424.251+3.391
YOY4.9405.436-0.496
5Y5.0516.045-0.994
10Y5.0516.363-1.312
1.3.2. Quick Ratio

Measures if SK Bioscience Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 8.55 means the company can pay off ₩8.55 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SK Bioscience Co Ltd:

  • The MRQ is 8.554. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.656. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.554TTM5.656+2.897
TTM5.656YOY3.874+1.782
TTM5.6565Y3.946+1.710
5Y3.94610Y3.9460.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5543.629+4.925
TTM5.6564.065+1.591
YOY3.8745.397-1.523
5Y3.9465.993-2.047
10Y3.9466.277-2.331

1.4. Solvency of SK Bioscience Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of SK Bioscience Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SK Bioscience Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that SK Bioscience Co Ltd assets are financed with 8.0% credit (debt) and the remaining percentage (100% - 8.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SK Bioscience Co Ltd:

  • The MRQ is 0.080. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.115. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.115-0.035
TTM0.115YOY0.188-0.073
TTM0.1155Y0.233-0.118
5Y0.23310Y0.2330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.332-0.252
TTM0.1150.334-0.219
YOY0.1880.268-0.080
5Y0.2330.366-0.133
10Y0.2330.390-0.157
1.4.2. Debt to Equity Ratio

Measures if SK Bioscience Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.7% means that company has ₩0.09 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SK Bioscience Co Ltd:

  • The MRQ is 0.087. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.131. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.131-0.043
TTM0.131YOY0.231-0.100
TTM0.1315Y0.356-0.225
5Y0.35610Y0.3560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0870.381-0.294
TTM0.1310.390-0.259
YOY0.2310.334-0.103
5Y0.3560.434-0.078
10Y0.3560.466-0.110

2. Market Valuation of SK Bioscience Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings SK Bioscience Co Ltd generates.

  • Above 15 is considered overpriced but always compare SK Bioscience Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 331.66 means the investor is paying ₩331.66 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SK Bioscience Co Ltd:

  • The EOD is 268.093. Based on the earnings, the company is expensive. -2
  • The MRQ is 331.662. Based on the earnings, the company is expensive. -2
  • The TTM is 41.474. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD268.093MRQ331.662-63.569
MRQ331.662TTM41.474+290.188
TTM41.474YOY68.853-27.379
TTM41.4745Y46.115-4.642
5Y46.11510Y46.1150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD268.093-2.315+270.408
MRQ331.662-2.560+334.222
TTM41.474-2.664+44.138
YOY68.853-4.122+72.975
5Y46.115-6.258+52.373
10Y46.115-6.108+52.223
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SK Bioscience Co Ltd:

  • The EOD is 23.234. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 28.743. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 2.146. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD23.234MRQ28.743-5.509
MRQ28.743TTM2.146+26.597
TTM2.146YOY-141.968+144.114
TTM2.1465Y-39.145+41.291
5Y-39.14510Y-39.1450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.234-3.067+26.301
MRQ28.743-3.251+31.994
TTM2.146-3.545+5.691
YOY-141.968-5.595-136.373
5Y-39.145-8.315-30.830
10Y-39.145-8.708-30.437
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of SK Bioscience Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.25 means the investor is paying ₩3.25 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of SK Bioscience Co Ltd:

  • The EOD is 2.624. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.247. Based on the equity, the company is fair priced.
  • The TTM is 3.260. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.624MRQ3.247-0.622
MRQ3.247TTM3.260-0.014
TTM3.260YOY4.703-1.443
TTM3.2605Y5.251-1.991
5Y5.25110Y5.2510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6241.905+0.719
MRQ3.2472.111+1.136
TTM3.2602.095+1.165
YOY4.7032.836+1.867
5Y5.2513.443+1.808
10Y5.2513.794+1.457
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SK Bioscience Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---247.943-123.154-50%456.833-154%1584.113-116%1584.113-116%
Book Value Per Share--22177.58822341.107-1%22035.010+1%18418.081+20%18418.081+20%
Current Ratio--10.1977.642+33%4.940+106%5.051+102%5.051+102%
Debt To Asset Ratio--0.0800.115-30%0.188-57%0.233-66%0.233-66%
Debt To Equity Ratio--0.0870.131-33%0.231-62%0.356-75%0.356-75%
Dividend Per Share----0%-0%-0%-0%
Eps--54.27272.623-25%398.462-86%503.905-89%503.905-89%
Free Cash Flow Per Share--626.237-68.169+111%-630.991+201%385.810+62%385.810+62%
Free Cash Flow To Equity Per Share--626.237-68.169+111%-667.941+207%1265.693-51%1265.693-51%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---10832.950--------
Intrinsic Value_10Y_min---8551.472--------
Intrinsic Value_1Y_max--872.917--------
Intrinsic Value_1Y_min--858.567--------
Intrinsic Value_3Y_max--1130.193--------
Intrinsic Value_3Y_min--1109.107--------
Intrinsic Value_5Y_max---411.972--------
Intrinsic Value_5Y_min---253.920--------
Market Cap4471377960000.000-24%5531601600000.0005594984535000.000-1%7899818535000.000-30%8105881670000.000-32%8105881670000.000-32%
Net Profit Margin--0.046-0.260+666%0.270-83%0.143-68%0.143-68%
Operating Margin----0%0.237-100%0.219-100%0.219-100%
Operating Ratio--1.7692.378-26%0.722+145%1.311+35%1.311+35%
Pb Ratio2.624-24%3.2473.2600%4.703-31%5.251-38%5.251-38%
Pe Ratio268.093-24%331.66241.474+700%68.853+382%46.115+619%46.115+619%
Price Per Share58200.000-24%72000.00072825.000-1%102825.000-30%105507.143-32%105507.143-32%
Price To Free Cash Flow Ratio23.234-24%28.7432.146+1239%-141.968+594%-39.145+236%-39.145+236%
Price To Total Gains Ratio-234.731+19%-290.389-151.950-48%245.517-218%81.618-456%81.618-456%
Quick Ratio--8.5545.656+51%3.874+121%3.946+117%3.946+117%
Return On Assets--0.0020.003-27%0.015-85%0.024-90%0.024-90%
Return On Equity--0.0020.003-24%0.018-86%0.035-93%0.035-93%
Total Gains Per Share---247.943-123.154-50%456.833-154%1584.113-116%1584.113-116%
Usd Book Value--1192698721.4661201492645.810-1%1185030923.774+1%990514473.152+20%990514473.152+20%
Usd Book Value Change Per Share---0.174-0.086-50%0.320-154%1.109-116%1.109-116%
Usd Book Value Per Share--15.52415.639-1%15.425+1%12.893+20%12.893+20%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0380.051-25%0.279-86%0.353-89%0.353-89%
Usd Free Cash Flow--33678685.817-3666097.444+111%-33934348.980+201%20748634.260+62%20748634.260+62%
Usd Free Cash Flow Per Share--0.438-0.048+111%-0.442+201%0.270+62%0.270+62%
Usd Free Cash Flow To Equity Per Share--0.438-0.048+111%-0.468+207%0.886-51%0.886-51%
Usd Market Cap3129964572.000-24%3872121120.0003916489174.500-1%5529872974.500-30%5674117169.000-32%5674117169.000-32%
Usd Price Per Share40.740-24%50.40050.978-1%71.978-30%73.855-32%73.855-32%
Usd Profit--2918727.4063905600.864-25%21429091.259-86%27099752.193-89%27099752.193-89%
Usd Revenue--63422951.61364663472.274-2%79927027.485-21%96046520.471-34%96046520.471-34%
Usd Total Gains Per Share---0.174-0.086-50%0.320-154%1.109-116%1.109-116%
 EOD+5 -3MRQTTM+13 -19YOY+14 -195Y+12 -2110Y+12 -21

3.2. Fundamental Score

Let's check the fundamental score of SK Bioscience Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15268.093
Price to Book Ratio (EOD)Between0-12.624
Net Profit Margin (MRQ)Greater than00.046
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.554
Current Ratio (MRQ)Greater than110.197
Debt to Asset Ratio (MRQ)Less than10.080
Debt to Equity Ratio (MRQ)Less than10.087
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.002
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of SK Bioscience Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.659
Ma 20Greater thanMa 5060,370.000
Ma 50Greater thanMa 10061,892.000
Ma 100Greater thanMa 20064,753.000
OpenGreater thanClose57,200.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets1,852,439,180
Total Liabilities148,583,864
Total Stockholder Equity1,703,855,316
 As reported
Total Liabilities 148,583,864
Total Stockholder Equity+ 1,703,855,316
Total Assets = 1,852,439,180

Assets

Total Assets1,852,439,180
Total Current Assets1,382,969,484
Long-term Assets469,469,697
Total Current Assets
Cash And Cash Equivalents 127,025,639
Short-term Investments 1,147,115,602
Net Receivables 12,928,077
Inventory 80,649,374
Other Current Assets 0
Total Current Assets  (as reported)1,382,969,484
Total Current Assets  (calculated)1,367,718,692
+/- 15,250,791
Long-term Assets
Property Plant Equipment 315,923,229
Intangible Assets 22,458,595
Long-term Assets Other 85,679
Long-term Assets  (as reported)469,469,697
Long-term Assets  (calculated)338,467,503
+/- 131,002,193

Liabilities & Shareholders' Equity

Total Current Liabilities135,619,896
Long-term Liabilities12,963,968
Total Stockholder Equity1,703,855,316
Total Current Liabilities
Accounts payable 3,370,136
Other Current Liabilities 0
Total Current Liabilities  (as reported)135,619,896
Total Current Liabilities  (calculated)3,370,136
+/- 132,249,760
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt20,573,529
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)12,963,968
Long-term Liabilities  (calculated)20,573,528
+/- 7,609,560
Total Stockholder Equity
Retained Earnings 549,420,553
Total Stockholder Equity (as reported)1,703,855,316
Total Stockholder Equity (calculated)549,420,553
+/- 1,154,434,763
Other
Capital Stock38,413,875
Common Stock Shares Outstanding 76,828
Net Invested Capital 1,703,855,316
Net Working Capital 1,247,349,588
Property Plant and Equipment Gross 315,923,229



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
525,852,423
562,231,772
1,709,925,403
1,791,924,931
1,919,181,605
2,110,122,672
2,001,425,224
2,094,066,245
2,099,319,713
2,141,931,384
2,022,254,238
1,968,519,935
1,920,136,633
1,852,439,180
1,852,439,1801,920,136,6331,968,519,9352,022,254,2382,141,931,3842,099,319,7132,094,066,2452,001,425,2242,110,122,6721,919,181,6051,791,924,9311,709,925,403562,231,772525,852,423
   > Total Current Assets 
293,143,944
333,902,157
1,458,196,444
1,537,120,784
1,659,208,055
1,837,804,231
1,703,675,115
1,779,157,664
1,780,999,320
1,783,694,210
1,646,947,548
1,574,104,787
1,448,571,128
1,382,969,484
1,382,969,4841,448,571,1281,574,104,7871,646,947,5481,783,694,2101,780,999,3201,779,157,6641,703,675,1151,837,804,2311,659,208,0551,537,120,7841,458,196,444333,902,157293,143,944
       Cash And Cash Equivalents 
14,229,805
24,972,321
35,333,690
51,289,632
81,280,467
98,028,261
191,744,043
145,716,351
87,530,247
225,287,448
242,656,903
243,754,562
247,513,805
127,025,639
127,025,639247,513,805243,754,562242,656,903225,287,44887,530,247145,716,351191,744,04398,028,26181,280,46751,289,63235,333,69024,972,32114,229,805
       Short-term Investments 
115,094,437
183,735,898
1,270,603,167
1,229,722,166
1,248,291,318
1,547,635,054
1,290,044,968
1,343,632,748
1,373,728,352
1,255,518,125
1,120,771,518
977,002,580
977,712,933
1,147,115,602
1,147,115,602977,712,933977,002,5801,120,771,5181,255,518,1251,373,728,3521,343,632,7481,290,044,9681,547,635,0541,248,291,3181,229,722,1661,270,603,167183,735,898115,094,437
       Net Receivables 
69,485,113
53,028,214
50,486,920
134,062,870
167,739,957
48,134,756
57,536,326
89,532,628
72,486,313
39,584,943
33,509,832
41,823,014
64,171,605
12,928,077
12,928,07764,171,60541,823,01433,509,83239,584,94372,486,31389,532,62857,536,32648,134,756167,739,957134,062,87050,486,92053,028,21469,485,113
       Inventory 
61,196,569
70,275,310
72,230,638
104,327,775
135,024,025
135,045,958
149,822,655
170,005,728
220,098,820
187,405,858
196,050,626
233,354,409
139,197,094
80,649,374
80,649,374139,197,094233,354,409196,050,626187,405,858220,098,820170,005,728149,822,655135,045,958135,024,025104,327,77572,230,63870,275,31061,196,569
       Other Current Assets 
0
1,149,643
28,947,634
17,033,508
23,203,828
7,553,640
13,808,888
29,616,517
25,831,197
0
-1
0
0
0
000-1025,831,19729,616,51713,808,8887,553,64023,203,82817,033,50828,947,6341,149,6430
   > Long-term Assets 
232,708,478
228,329,614
251,728,959
254,804,147
259,973,550
272,318,441
297,750,109
314,908,582
318,320,392
358,237,173
375,306,690
394,415,147
471,565,505
469,469,697
469,469,697471,565,505394,415,147375,306,690358,237,173318,320,392314,908,582297,750,109272,318,441259,973,550254,804,147251,728,959228,329,614232,708,478
       Property Plant Equipment 
0
189,478,939
193,451,735
202,578,266
207,284,678
220,983,379
246,015,383
284,011,365
285,895,271
293,056,611
292,082,198
299,329,248
298,706,017
315,923,229
315,923,229298,706,017299,329,248292,082,198293,056,611285,895,271284,011,365246,015,383220,983,379207,284,678202,578,266193,451,735189,478,9390
       Intangible Assets 
18,420,824
17,857,570
17,930,034
17,913,623
17,613,112
17,061,308
16,942,062
17,965,905
18,537,522
18,181,330
19,176,939
19,110,280
24,327,692
22,458,595
22,458,59524,327,69219,110,28019,176,93918,181,33018,537,52217,965,90516,942,06217,061,30817,613,11217,913,62317,930,03417,857,57018,420,824
       Long-term Assets Other 
24,572
85,680
85,680
85,680
-2,710,140
-3,194,066
-5,333,073
1,652
85,680
85,680
85,680
85,680
85,680
85,679
85,67985,68085,68085,68085,68085,6801,652-5,333,073-3,194,066-2,710,14085,68085,68085,68024,572
> Total Liabilities 
272,395,689
298,441,527
419,370,091
448,274,265
498,934,587
508,810,724
367,793,250
406,364,738
390,749,911
400,229,387
294,737,698
257,123,752
197,232,410
148,583,864
148,583,864197,232,410257,123,752294,737,698400,229,387390,749,911406,364,738367,793,250508,810,724498,934,587448,274,265419,370,091298,441,527272,395,689
   > Total Current Liabilities 
147,236,438
180,639,495
323,568,929
354,151,950
448,670,122
459,952,164
311,184,020
378,451,544
364,163,624
380,037,427
277,202,273
241,305,987
183,244,760
135,619,896
135,619,896183,244,760241,305,987277,202,273380,037,427364,163,624378,451,544311,184,020459,952,164448,670,122354,151,950323,568,929180,639,495147,236,438
       Short Long Term Debt 
10,992,109
10,994,490
10,996,877
10,999,306
59,683,470
59,649,065
59,907,857
139,755,267
101,847,252
83,558,456
39,100,588
0
0
0
00039,100,58883,558,456101,847,252139,755,26759,907,85759,649,06559,683,47010,999,30610,996,87710,994,49010,992,109
       Accounts payable 
24,721,384
17,505,191
13,057,000
41,969,436
64,473,560
63,811,952
15,784,001
18,383,292
33,358,470
11,053,234
7,077,113
5,996,684
10,312,355
3,370,136
3,370,13610,312,3555,996,6847,077,11311,053,23433,358,47018,383,29215,784,00163,811,95264,473,56041,969,43613,057,00017,505,19124,721,384
       Other Current Liabilities 
0
139,006,146
292,443,175
289,433,450
303,039,589
307,859,959
223,161,826
202,104,627
205,677,872
1
0
0
0
0
00001205,677,872202,104,627223,161,826307,859,959303,039,589289,433,450292,443,175139,006,1460
   > Long-term Liabilities 
125,159,250
117,802,032
95,801,163
94,122,315
50,264,465
48,858,559
56,609,230
27,913,194
26,586,288
20,191,960
17,535,425
15,817,765
13,987,650
12,963,968
12,963,96813,987,65015,817,76517,535,42520,191,96026,586,28827,913,19456,609,23048,858,55950,264,46594,122,31595,801,163117,802,032125,159,250
       Long term Debt 
106,488,424
102,233,018
81,857,858
81,773,086
35,473,015
35,502,635
36,273,583
0
0
0
0
0
0
0
000000036,273,58335,502,63535,473,01581,773,08681,857,858102,233,018106,488,424
       Capital Lease Obligations Min Short Term Debt
7,745,066
8,739,559
9,404,458
9,583,369
11,538,218
11,083,885
19,173,793
27,257,831
25,603,988
29,777,737
28,869,262
26,425,379
23,554,202
20,573,529
20,573,52923,554,20226,425,37928,869,26229,777,73725,603,98827,257,83119,173,79311,083,88511,538,2189,583,3699,404,4588,739,5597,745,066
       Other Liabilities 
0
8,443,055
6,326,005
4,747,441
5,610,209
4,581,298
6,965,598
9,345,070
9,837,683
0
0
0
0
0
000009,837,6839,345,0706,965,5984,581,2985,610,2094,747,4416,326,0058,443,0550
       Long-term Liabilities Other 
-1
1
0
0
0
0
0
0
1
0
0
0
0
0
0000010000001-1
       Deferred Long Term Liability 
0
15,221,386
14,643,012
14,064,637
13,563,225
13,088,066
12,552,841
13,081,393
12,494,409
0
0
0
0
0
0000012,494,40913,081,39312,552,84113,088,06613,563,22514,064,63714,643,01215,221,3860
> Total Stockholder Equity
253,456,734
263,790,244
1,290,555,312
1,343,650,666
1,420,247,018
1,601,311,948
1,633,631,974
1,687,701,507
1,708,569,801
1,741,701,996
1,727,516,540
1,711,396,182
1,722,904,223
1,703,855,316
1,703,855,3161,722,904,2231,711,396,1821,727,516,5401,741,701,9961,708,569,8011,687,701,5071,633,631,9741,601,311,9481,420,247,0181,343,650,6661,290,555,312263,790,244253,456,734
   Common Stock
0
30,600,000
38,250,000
38,250,000
38,250,000
38,250,000
38,300,000
38,392,023
38,392,023
0
0
0
0
0
0000038,392,02338,392,02338,300,00038,250,00038,250,00038,250,00038,250,00030,600,0000
   Retained Earnings 
43,140,085
53,236,251
95,160,916
147,972,696
224,409,997
405,305,164
433,111,479
479,237,421
500,015,550
533,377,516
519,258,549
503,133,663
551,525,624
549,420,553
549,420,553551,525,624503,133,663519,258,549533,377,516500,015,550479,237,421433,111,479405,305,164224,409,997147,972,69695,160,91653,236,25143,140,085
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
-564,040
80,532
364,107
523,157
692,921
4,131,971
10,063,932
10,154,097
0
0
0
0
0
0000010,154,09710,063,9324,131,971692,921523,157364,10780,532-564,0400



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue369,505,556
Cost of Revenue-227,262,754
Gross Profit142,242,802142,242,802
 
Operating Income (+$)
Gross Profit142,242,802
Operating Expense-381,493,321
Operating Income-11,987,765-239,250,519
 
Operating Expense (+$)
Research Development85,743,416
Selling General Administrative25,347,506
Selling And Marketing Expenses0
Operating Expense381,493,321111,090,922
 
Net Interest Income (+$)
Interest Income13,555,354
Interest Expense-1,398,139
Other Finance Cost-0
Net Interest Income12,157,215
 
Pretax Income (+$)
Operating Income-11,987,765
Net Interest Income12,157,215
Other Non-Operating Income Expenses0
Income Before Tax (EBT)7,327,227-11,987,765
EBIT - interestExpense = -1,398,139
22,317,719
23,715,858
Interest Expense1,398,139
Earnings Before Interest and Taxes (EBIT)08,725,366
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax7,327,227
Tax Provision--14,990,492
Net Income From Continuing Ops22,317,71922,317,719
Net Income22,317,719
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-12,157,215
 

Technical Analysis of SK Bioscience Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SK Bioscience Co Ltd. The general trend of SK Bioscience Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SK Bioscience Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SK Bioscience Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 60,200 < 60,200 < 63,100.

The bearish price targets are: .

Tweet this
SK Bioscience Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SK Bioscience Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SK Bioscience Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SK Bioscience Co Ltd. The current macd is -1,185.21324262.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SK Bioscience Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for SK Bioscience Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the SK Bioscience Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SK Bioscience Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSK Bioscience Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SK Bioscience Co Ltd. The current adx is 26.01.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell SK Bioscience Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
SK Bioscience Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SK Bioscience Co Ltd. The current sar is 59,742.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
SK Bioscience Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SK Bioscience Co Ltd. The current rsi is 38.66. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
SK Bioscience Co Ltd Daily Relative Strength Index (RSI) ChartSK Bioscience Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SK Bioscience Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the SK Bioscience Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
SK Bioscience Co Ltd Daily Stochastic Oscillator ChartSK Bioscience Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SK Bioscience Co Ltd. The current cci is -106.99406408.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
SK Bioscience Co Ltd Daily Commodity Channel Index (CCI) ChartSK Bioscience Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SK Bioscience Co Ltd. The current cmo is -22.04580564.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
SK Bioscience Co Ltd Daily Chande Momentum Oscillator (CMO) ChartSK Bioscience Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SK Bioscience Co Ltd. The current willr is -72.72727273.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that SK Bioscience Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SK Bioscience Co Ltd Daily Williams %R ChartSK Bioscience Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SK Bioscience Co Ltd.

SK Bioscience Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SK Bioscience Co Ltd. The current atr is 1,235.

SK Bioscience Co Ltd Daily Average True Range (ATR) ChartSK Bioscience Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SK Bioscience Co Ltd. The current obv is 14,616,026.

SK Bioscience Co Ltd Daily On-Balance Volume (OBV) ChartSK Bioscience Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SK Bioscience Co Ltd. The current mfi is 29.85.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SK Bioscience Co Ltd Daily Money Flow Index (MFI) ChartSK Bioscience Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SK Bioscience Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

SK Bioscience Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SK Bioscience Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.659
Ma 20Greater thanMa 5060,370.000
Ma 50Greater thanMa 10061,892.000
Ma 100Greater thanMa 20064,753.000
OpenGreater thanClose57,200.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of SK Bioscience Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on SK Bioscience Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SK Bioscience Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SK Bioscience Co Ltd

I send you an email if I find something interesting about SK Bioscience Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about SK Bioscience Co Ltd.

Receive notifications about SK Bioscience Co Ltd in your mailbox!